Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends
How Is the Biopsy Needle Market Growth Forecast from 2025 to 2029?
The biopsy needle market size has grown strongly in recent years. It will grow from $1.30 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising demand for minimally invasive procedures, growing awareness about early diagnosis, rise in the geriatric population, increasing adoption of image-guided biopsy techniques, and increasing need for early and accurate diagnosis.
The biopsy needle market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing demand for advanced diagnostic tools, rising number of screening programs, expansion of the private healthcare sector in emerging economies, increasing the availability of biopsy procedures, and increasing emphasis on patient safety. Major trends in the forecast period include advancement in needle design and precision, innovation in imaging technologies for biopsy guidance, integration of robotic-assisted biopsy systems, advanced real-time data monitoring during procedures, and innovation in disposable biopsy needles for infection control.
Claim your free report sample now:
What Are the Key Growth Factors Supporting the Biopsy Needle Market Expansion?
The increasing demand for minimally invasive procedures is expected to propel the growth of the biopsy needle market going forward. Minimally invasive procedures refer to medical interventions performed through small incisions or openings, reducing patient trauma and recovery time. The demand for minimally invasive surgical procedures is increasing due to their ability to offer shorter recovery times, reduced risks of complications, less pain, and smaller scars, making them more appealing to patients seeking quicker and safer treatment options. Biopsy needles aid in minimally invasive procedures by enabling precise tissue sampling, reducing the need for surgical intervention. They support quicker diagnoses and recovery times, improving patient comfort and procedural efficiency. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biopsy needle market.
What Segments Are Covered in the Biopsy Needle Market Report?
The biopsy needle market covered in this report is segmented
1) By Type: Disposable, Non-Disposable
2) By Product: Needle Based Biopsy Guns, Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices
3) By Procedure: Image-Guided Procedures, Non-Image-Guided Procedures
4) By Application: Cancer Or Tumor, Breast, Lung, Prostate, Colon, Stomach, Liver, Rectum, Cervix Uteri, Other Applications
5) By End-User: Hospitals And Surgical Centers, Diagnostic Clinics And Pathology Laboratories, Ambulatory Care Centers, Research And Academic Institutes
Subsegments:
1) By Disposable: Coaxial Biopsy Needles, Chiba Needles, Jamshidi Needles
2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles, Reusable Menghini Needles, Reusable Francine Needles
What Are the Key Trends Shaping the Biopsy Needle Market?
Major companies operating in the biopsy needle market are focusing on developing technologically advanced products, such as semi-automatic core biopsy instruments, to enhance precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that use a spring-loaded mechanism to quickly and accurately collect tissue samples with minimal manual effort during a biopsy procedure. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, launched the SuperCore Advantage semi-automatic biopsy instrument. It is a semi-automatic, disposable core biopsy needle that provides consistent, high-quality tissue samples for accurate diagnosis. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to accommodate different lesion depths. The device also enhances biopsy precision while reducing patient discomfort, offering improved diagnostic options for patients.
Who Are the Key Players Driving the Biopsy Needle Market?
Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.
Get the full biopsy needle market report here:
How Does Biopsy Needle Market Growth Vary Across Major Regions?
North America was the largest region in the biopsy needle market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment